Immunity & Infection

·

Review

Reishi Moves Toward Drug and Biotech Development

Reishi Moves Toward Drug and Biotech Development

Reishi

What they found

A review covers reishi's compounds and their growing use in drug delivery, nanomaterials, biosensors and functional foods.

A review covers reishi's compounds and their growing use in drug delivery, nanomaterials, biosensors and functional foods.

How solid is it?

Review

Review

Narrative review

Narrative review

Evidence ladder: Lab dish → Animal → Early human → Strong human. Reviews summarize earlier research.

At a glance

Latin name

Ganoderma lucidum

Ganoderma lucidum

Compound

polysaccharides, triterpenoids

polysaccharides, triterpenoids

Published in

Phytotherapy Research : PTR

Phytotherapy Research : PTR

Covered in Shroom Scan

Section

HEALTH & WELLNESS

HEALTH & WELLNESS

As it ran in Shroom Scan

Reishi Clinical Push

Reishi Clinical Push

Reishi (Ganoderma lucidum) contains polysaccharides, triterpenoids, sterols, and phenolic compounds tied to immune signaling, inflammation control, antioxidant defense, liver protection, and anticancer pathways, with research now expanding into drug delivery systems, antimicrobial nanomaterials, and functional foods. Scientists are also developing reishi-based nanoparticles and biosensors while exploring applications in skin health, anti-aging products, and metabolic support, signaling a shift from traditional remedy toward pharmaceutical and biotech integration. The review highlights one of the clearest examples of a medicinal mushroom moving beyond vague wellness positioning into clinically targeted therapeutic development.

Reishi (Ganoderma lucidum) contains polysaccharides, triterpenoids, sterols, and phenolic compounds tied to immune signaling, inflammation control, antioxidant defense, liver protection, and anticancer pathways, with research now expanding into drug delivery systems, antimicrobial nanomaterials, and functional foods. Scientists are also developing reishi-based nanoparticles and biosensors while exploring applications in skin health, anti-aging products, and metabolic support, signaling a shift from traditional remedy toward pharmaceutical and biotech integration. The review highlights one of the clearest examples of a medicinal mushroom moving beyond vague wellness positioning into clinically targeted therapeutic development.

Shroom Scan #116: Psilocybin cuts cocaine relapse 72%, 24M Americans microdosing, and lion's mane coffee

Read the original study ↗

Get Shroom Scan

Next study

Oyster Mushroom Powder Helped Burned Skin Heal in Rats ›

Shroom Scan · Every Friday

Get Studies Like This, Translated, Every Week

Ten new studies a week, each boiled down to what it found and why it matters to you. Free, and one click to leave.

See what's inside →